In addition, the unique characteristics of pEVs, such as their ability to circulate for extended periods and their capacity to penetrate tissue barriers like the blood–brain barrier, make them attractive candidates for regenerative medicine and drug delivery since pEVs also possess key surface markers, like CD41 and CD62P, that mediate targeting to inflammation and tumor sites [109]. The gene discussed is SELP; the disease is neoplasm.